Package 24979-248-06

Brand: bupropion hydrochloride

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 24979-248-06
Digits Only 2497924806
Product NDC 24979-248
Product ID 24979-248_0c147f44-e89f-4559-b3d3-cf9301adf56f
Description

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24979-248-06)

Marketing

Marketing Status
Marketed Since 2023-12-15
Brand bupropion hydrochloride
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

bupropion hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "0c147f44-e89f-4559-b3d3-cf9301adf56f", "openfda": {"upc": ["0324979248066"], "unii": ["ZG7E5POY8O"], "rxcui": ["1232585"], "spl_set_id": ["98d5977f-9b32-46db-bd36-a2c4d1b0710a"], "manufacturer_name": ["Upsher-Smith Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24979-248-06)", "package_ndc": "24979-248-06", "marketing_start_date": "20231215"}], "brand_name": "bupropion hydrochloride", "product_id": "24979-248_0c147f44-e89f-4559-b3d3-cf9301adf56f", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "24979-248", "generic_name": "bupropion hydrochloride", "labeler_name": "Upsher-Smith Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "bupropion hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "450 mg/1"}], "application_number": "NDA022497", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20231215", "listing_expiration_date": "20261231"}